Articles tagged with Hiv Research
A recent study found that risk factors for HIV infection among married women in India include having a sex partner with a sexually transmitted disease. The researchers discovered a significant correlation between HIV transmission and the cultural norm of not discussing sexual behavior, emphasizing the need for accessible STD prevention...
A study published in the Journal of the American Medical Association found that certain symptoms like fever, joint pain, and night sweats can identify people with recent HIV infection before a positive blood test. The researchers screened over 3,800 patients and found that those with these symptoms were more likely to have the virus.
The FDA has approved the first phase of a new AIDS vaccine developed at St. Jude Children's Research Hospital, which aims to trigger immune responses to multiple HIV isolates using envelope proteins. The vaccine combines 23 different envelopes representing various HIV strains and is expected to last one to two years.
The study aims to measure how effectively combination drug therapy works during the early stages of HIV infection, with a focus on reducing damage caused by the virus. Researchers hope to determine the optimal duration of treatment for maximum benefit and assess the impact of early treatment on immune system chemicals.
Researchers have found that cidofovir, a new antiviral drug, can slow the progression of cytomegalovirus (CMV) retinitis, a common cause of vision loss and blindness in AIDS patients. The study showed that both low and high doses of the drug were effective, allowing for less frequent treatment compared to traditional options.
A recent NIH study found that a combination of a protease inhibitor and two nucleoside analogue reverse transcriptase inhibitors can significantly reduce the occurrence of AIDS-defining illnesses or death. The study, ACTG 320, demonstrated improved survival and delayed disease progression in patients receiving triple combination therapy.
Researchers found a three-drug combination of indinavir, zidovudine, and lamivudine significantly reduces AIDS symptoms and prolongs patient survival compared to two-drug combinations. The study enrolled 1,156 participants and showed a 45% reduction in disease progression events.
Researchers have identified key chemokine receptors that enable HIV to infect immune system cells, including CCR5 and CCR-3. Understanding these interactions could lead to the development of new treatments and prevention strategies for HIV/AIDS.